Advanced Pharmacology Nsg 533 Study Guide Graded A+

Patients with known osteoporosis can remain on PPI therapy. Concern for hip fractures and osteoporosis should not affect the decision to use PPI long-term except in patients with other risk factors for hip fracture {Ans: }Non-pharmacologic interventions for BPH {Ans: Lifestyle modification - limiting EToH, caffeine, avoid certain medications (Table 52-4)(e.g. decongestants, androgens, etc) as well as addressing co-morbidities (weight loss, etc) Watchful waiting is the most conservative approach for patients with mild symptoms or those with moderate symptoms without bother ◦Appropriate option for patients with mild symptoms (AUA-SI score ≤ 7), and for many with moderate to severe symptoms (AUA-SI ≥ 8) if they are not bothered ◦Behavior modification includes restricting fluids close to bedtime, minimizing caffeine, sweetened drinks and alcohol intake, frequent emptying of the bladder during waking hours (to avoid overflow incontinence and urgency), and avoiding drugs that could exacerbate voiding symptoms (e.g. antihistamines, decongestants). ◦At each visit, assess the patient's risk of developing acute urinary retention by evaluating the patient's prostate size or using PSA as a surrogate marker of prostate enlargement The level of symptom distress that individual men are able to tolerate is variable}What are the goals set by ACE /ACCE and